Edwards Lifesciences (EW) PT Lowered to $80 at Barclays

Go back to Edwards Lifesciences (EW) PT Lowered to $80 at Barclays

Edwards Lifesciences (EW) PT Lowered to $80 at Wells Fargo

September 9, 2024 5:25 AM EDT

Wells Fargo analyst Lawrence Biegelsen lowered the price target on Edwards Lifesciences (NYSE: EW) to $80.00 (from $90.00) while maintaining a Overweight rating.

The analyst comments "Model updates. Our model excludes Critical Care starting in 3Q24. We estimate that Critical Care contributed ~$0.40 to... More